Background: Researchers have focused on isolating and identifying the bacteriocin producing lactic acid bacteria from various food systems especially dairy products. Molecular techniques have been recently used for rabid identification of bacteriocins rather than time-consuming biochemical characters. Global climate disturbances can affect the diversity of beneficial microorganisms in dairy and their products, especially lactic acid bacteria, so it is worth to evaluate their bacteriocinogenicity in different climates. Thus, the aim of this study was to screen for predominant bacteriocin producing lactic acid bacteria (LAB) in traditional dairy products of Luxor governorate at Upper Egypt and determine their bacteriocin-encoding genes. Results: Eighty-six strains of the LAB were isolated from raw milk and traditional dairy product of Luxor province, Egypt, in which 76.1% and 23.9% were identified as lactic acid bacilli and cocci, respectively. On the basis of their antibacterial potentials, 30 out of 68 LAB isolates were found to be antimicrobial producers. These isolates exhibited a potential antibacterial activity against Salmonella paratyphi B, Escherichia coli, Staphylococcus aureus, and Proteus mirabilis, except for Listeria monocytogenes. LAB isolates were analyzed using species-specific PCR; results emphasized that 22 of isolates were identified as Lactobacillus plantarum, while 8 were Leuconostoc mesenteroides. According to the sequencing of isolates, two strains named Lactobacillus plantarum Egypt 2018 (accession no. MH817034) and Leuconostoc mesenteroides Egypt 2018 (accession no. MH817035) were identified. Detection of bacteriocin-encoding genes was performed by polymerase chain reaction (PCR). The results emphasized that almost all tested Lb. plantarum strains (n = 10) possess both plnA and plnEF genes, whereas the gene encoding mesentericin Y105 was detected in one Lc. mesenteroides of the examined isolates. Conclusions: This study was effective for the rapid detection of bacteriocin producing strains within dairy products. Extracted bacteriocin could be a valuable source of natural food biopreservative.
Background Bacteriocins are proteinaceous compounds produced from lactic acid bacteria. Bacteriocins are well-known for their antibacterial potential and safety for application in food. However, the commercial availability of bacteriocin is facing several limitations; among them is the low yield and short stability period. That calls for a new strategy for overcoming these hurdles. Among these approaches is incorporating bacteriocin in nanoparticles. So, the aim of this study was to enhance the plantaricin produced from isolated Lactobacillus plantarum strain using nanotechnology. Results In this study, the plnEF genes encoding plantaricin EF have been identified and sequenced (accession number of MN172264.1). The extracted bacteriocin (EX-PL) was obtained by the ammonium sulfate method. Then, it was used for biosynthesizing plantaricin-incorporated silver nanoparticles (PL-SNPs). The synthesized nanoparticles were confirmed by SEM-EDAX analysis. The antibacterial activity of both combined (PL-SNPs) and extracted plantaricin (EX-PL) were tested against some strains of foodborne pathogenic bacteria. The results revealed that the antibacterial activities were increased by 99.2% on the combination of bacteriocin with the silver nanoparticle. The MIC of EX-PL (7.6 mg/mL) has been lowered after incorporating into silver nanoparticles and reached 0.004 mg/mL for PL-SNPs. Despite that extracted plantaricin showed no inhibitory activity towards Listeria monocytogenes, plantaricin-incorporated silver nanoparticles displayed inhibitory activity against this strain. Furthermore, the stability period at 4 °C was increased from 5 days to 60 days for EX-PL and PL-SNPs, respectively. Conclusions Plantaricin-incorporated silver nanoparticles possess higher antibacterial activity and more stability than the free one, which makes it more fitting for combating foodborne pathogens and open more fields for applications in both food and pharmaceutical industries. Graphical abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.